Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

Literature DB >> 10832853

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

R Peto, J Boreham, M Clarke, C Davies, V Beral.

Abstract

Entities: Disease

Mesh：

Year: 2000 PMID： 10832853 DOI： 10.1016/S0140-6736(00)02277-7

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

111 in total

Review 1. Adjuvant therapy for breast cancer: who should get what?

Authors: H K Chew
Journal: West J Med Date: 2001-04

2. Inequality in life expectancy, functional status, and active life expectancy across selected black and white populations in the United States.

Authors: A T Geronimus; J Bound; T A Waidmann; C G Colen; D Steffick
Journal: Demography Date: 2001-05

Review 3. Prognostic factors in breast cancer: current and new predictors of metastasis.

Authors: D F Hayes; C Isaacs; V Stearns
Journal: J Mammary Gland Biol Neoplasia Date: 2001-10 Impact factor: 2.673

Review 4. Hormone-induced protection against breast cancer.

Authors: Lakshmi Sivaraman; Daniel Medina
Journal: J Mammary Gland Biol Neoplasia Date: 2002-01 Impact factor: 2.673

5. Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.

Authors: Sylvia K Plevritis; Diego Munoz; Allison W Kurian; Natasha K Stout; Oguzhan Alagoz; Aimee M Near; Sandra J Lee; Jeroen J van den Broek; Xuelin Huang; Clyde B Schechter; Brian L Sprague; Juhee Song; Harry J de Koning; Amy Trentham-Dietz; Nicolien T van Ravesteyn; Ronald Gangnon; Young Chandler; Yisheng Li; Cong Xu; Mehmet Ali Ergun; Hui Huang; Donald A Berry; Jeanne S Mandelblatt
Journal: JAMA Date: 2018-01-09 Impact factor: 56.272

Review 10. Screening for breast cancer.

Authors: Joann G Elmore; Katrina Armstrong; Constance D Lehman; Suzanne W Fletcher
Journal: JAMA Date: 2005-03-09 Impact factor: 56.272

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

Review 1. Adjuvant therapy for breast cancer: who should get what?

2. Inequality in life expectancy, functional status, and active life expectancy across selected black and white populations in the United States.

Review 3. Prognostic factors in breast cancer: current and new predictors of metastasis.

Review 4. Hormone-induced protection against breast cancer.

5. Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.

6. 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study.

7. Physical Activity and Survival in Women With Advanced Breast Cancer.

8. Participation in the SUCCESS-A Trial Improves Intensity and Quality of Care for Patients with Primary Breast Cancer.

Review 9. State of the art of current modalities for the diagnosis of breast lesions.

Review 10. Screening for breast cancer.